Literature DB >> 32216695

A Program Review of Head Start and Elementary School Hearing Screenings.

Annette Hurley1, Michelle Willis1, Megan Guidry1, Dan Bode2, Marissa L Corneille1, Sara Mills1.   

Abstract

Purpose The purpose of this study was to review quality benchmarks from hearing screening programs conducted at local Head Start centers and preschool and elementary schools associated with our university training programs. Method Hearing screening results from 6,043 children were reviewed. Hearing screening was accomplished using either distortion product otoacoustic emissions (DPOAEs) at Head Start centers, pure-tone audiometry at preschool and elementary schools, and tympanometry at all settings. All children who did not pass the initial screening were screened a second time. Referrals were made if a child did not pass the automated DPOAE pass criteria for one ear, failed at least one pure-tone frequency for one ear, or had abnormal tympanometry in one ear. Results Refer rates were 10.9% for DPOAEs and 11.4% for pure-tone audiometry and tympanometry, with an overall refer rate of 11%. Conclusions Our hearing screening program review yielded refer rates that are similar to other published reports for this population. Presently, there are no published target refer rates for hearing screening programs in preschool and elementary schools. Although we were not able to complete other program quality benchmark indicators including sensitivity and specificity, these data may support benchmarks for other hearing screening programs.

Entities:  

Mesh:

Year:  2020        PMID: 32216695     DOI: 10.1044/2019_LSHSS-19-00012

Source DB:  PubMed          Journal:  Lang Speech Hear Serv Sch        ISSN: 0161-1461            Impact factor:   2.983


  1 in total

1.  Results of Hearing Screening in School-Age Children from Rural Areas of the Kujawsko- Pomorskie Region in Poland.

Authors:  Elzbieta Gos; Piotr Henryk Skarzynski; Natalia Czajka; Monika Matusiak; Wojciech Kazmierczak; Joanna Janiak-Kiszka; Katarzyna Beata Cywka; Henryk Skarzynski
Journal:  J Int Adv Otol       Date:  2022-03       Impact factor: 1.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.